Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)
China
· Delayed Price · Currency is CNY 13.96
-0.19 (-1.34%)
Apr 29, 2026, 3:00 PM CST
SHA:603456 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 12,309 | 15,783 | 12,247 | 21,777 | 35,397 | 46,842 | Upgrade
|
| Market Cap Growth | -0.66% | 28.87% | -43.76% | -38.48% | -24.43% | 62.49% | Upgrade
|
| Enterprise Value | 10,921 | 13,276 | 10,155 | 18,935 | 34,444 | 46,532 | Upgrade
|
| Last Close Price | 13.96 | 17.90 | 13.26 | 22.60 | 39.01 | 51.48 | Upgrade
|
| PE Ratio | 19.13 | 21.62 | 20.21 | 21.08 | 38.43 | 73.90 | Upgrade
|
| Forward PE | 12.15 | 14.44 | 10.72 | 15.86 | 32.74 | 63.29 | Upgrade
|
| PS Ratio | 2.36 | 2.87 | 2.37 | 3.94 | 6.50 | 11.53 | Upgrade
|
| PB Ratio | 1.37 | 1.80 | 1.42 | 2.55 | 6.59 | 10.23 | Upgrade
|
| P/TBV Ratio | 1.46 | 1.91 | 1.54 | 2.78 | 7.48 | 11.44 | Upgrade
|
| P/FCF Ratio | 11.83 | 13.56 | 119.26 | 50.54 | 69.14 | 479.75 | Upgrade
|
| P/OCF Ratio | 7.35 | 8.65 | 12.35 | 16.01 | 28.88 | 69.14 | Upgrade
|
| EV/Sales Ratio | 2.09 | 2.41 | 1.97 | 3.43 | 6.33 | 11.45 | Upgrade
|
| EV/EBITDA Ratio | 6.95 | 8.06 | 9.15 | 12.80 | 25.17 | 45.74 | Upgrade
|
| EV/EBIT Ratio | 9.62 | 10.77 | 14.20 | 17.17 | 33.58 | 64.10 | Upgrade
|
| EV/FCF Ratio | 10.50 | 11.40 | 98.89 | 43.95 | 67.28 | 476.58 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.05 | 0.05 | 0.07 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.06 | 0.04 | 0.37 | 0.28 | 0.26 | 0.69 | Upgrade
|
| Debt / FCF Ratio | 0.10 | 0.06 | 4.01 | 0.96 | 0.69 | 7.22 | Upgrade
|
| Net Debt / Equity Ratio | -0.16 | -0.17 | -0.27 | -0.33 | -0.14 | -0.10 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.93 | -0.90 | -2.11 | -1.89 | -0.54 | -0.43 | Upgrade
|
| Net Debt / FCF Ratio | -1.39 | -1.27 | -22.76 | -6.48 | -1.45 | -4.53 | Upgrade
|
| Asset Turnover | 0.48 | 0.51 | 0.47 | 0.59 | 0.73 | 0.68 | Upgrade
|
| Inventory Turnover | 2.13 | 2.08 | 1.84 | 1.77 | 1.96 | 1.93 | Upgrade
|
| Quick Ratio | 1.89 | 1.70 | 1.96 | 2.54 | 0.84 | 0.96 | Upgrade
|
| Current Ratio | 3.83 | 3.51 | 2.97 | 3.81 | 1.80 | 1.81 | Upgrade
|
| Return on Equity (ROE) | 7.26% | 8.37% | 7.08% | 14.84% | 18.51% | 16.55% | Upgrade
|
| Return on Assets (ROA) | 6.57% | 7.09% | 4.07% | 7.34% | 8.58% | 7.54% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.97% | 14.39% | 9.89% | 18.58% | 19.54% | 15.84% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.40% | 13.70% | 7.90% | 12.00% | 18.00% | 14.60% | Upgrade
|
| Earnings Yield | 5.30% | 4.63% | 4.95% | 4.75% | 2.60% | 1.35% | Upgrade
|
| FCF Yield | 8.45% | 7.38% | 0.84% | 1.98% | 1.45% | 0.21% | Upgrade
|
| Dividend Yield | 2.12% | - | 2.26% | 2.21% | 1.03% | 0.49% | Upgrade
|
| Payout Ratio | 68.99% | 61.69% | 77.76% | 37.37% | 25.50% | 30.07% | Upgrade
|
| Buyback Yield / Dilution | -0.71% | 0.11% | -0.07% | -7.33% | 0.50% | -3.00% | Upgrade
|
| Total Shareholder Return | 1.41% | 0.11% | 2.20% | -5.12% | 1.53% | -2.52% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.